Large-scale testing (Phase 3)UnknownNCT00715637
What this trial is testing
Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study
Who this might be right for
Secondary Acute Myeloid Leukemia (Secondary AML, sAML)
Antisoma Research 420